Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

Monday’s Trading Day
12.35 +0.205 / +1.69%
As of Mar 02
Day’s Change
Tuesday’s Pre-Market   Switch to standard view »
12.30 -0.045 / -0.36%
 
Volume: 10.5K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.4B

Company Description

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops and commercializes innovative treatments for infectious diseases. The company is currently engaged in the development of antivirals for the treatment of chronic hepatitis C infection and resistant bacterial infections. Its products include ACH-3102, ACH-2684, Sovaprevir and ACH-3422. Achillion Pharmaceuticals was founded on August 17, 1998 and is headquartered in New Haven, CT.

Contact Information

Achillion Pharmaceuticals, Inc.
300 George Street
New Haven Connecticut 06511
P:(203) 624-7000
Investor Relations:
(203) 752-5510

Employees

Shareholders

Other institutional45.87%
Mutual fund holders42.29%
Individual stakeholders36.19%

Top Executives

Milind S. DeshpandePresident, Chief Executive Officer & Director
Mary Kay FentonCFO, Secretary, EVP & Investor Relations Contact
David ApelianChief Medical Officer & Executive Vice President
Joseph TruittChief Commercial Officer & Executive VP
Glenn SchulmanHead-Investor Relations

To view my watchlist

Not a member yet?

Sign up now for a free account